Sarepta Cash from 2010 to 2025
| SRPT Stock | USD 73.45 6.52 8.15% |
Cash | First Reported 1996-12-31 | Previous Quarter 197.9 M | Current Value 1.1 B | Quarterly Volatility 477 M |
Check Sarepta Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sarepta Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.6 M, Interest Expense of 10.6 M or Selling General Administrative of 585.8 M, as well as many indicators such as Price To Sales Ratio of 5.77, Dividend Yield of 0.0 or PTB Ratio of 6.75. Sarepta financial statements analysis is a perfect complement when working with Sarepta Therapeutics Valuation or Volatility modules.
Sarepta | Cash |
Latest Sarepta Therapeutics' Cash Growth Pattern
Below is the plot of the Cash of Sarepta Therapeutics over the last few years. Cash refers to the most liquid asset of Sarepta Therapeutics, which is listed under current asset account on Sarepta Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Sarepta Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Sarepta Therapeutics account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Sarepta Therapeutics' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sarepta Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Sarepta Cash Regression Statistics
| Arithmetic Mean | 615,124,969 | |
| Geometric Mean | 254,216,886 | |
| Coefficient Of Variation | 100.05 | |
| Mean Deviation | 498,849,336 | |
| Median | 428,430,000 | |
| Standard Deviation | 615,421,672 | |
| Sample Variance | 378743.8T | |
| Range | 2.1B | |
| R-Value | 0.72 | |
| Mean Square Error | 193778.2T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | 93,435,465 | |
| Total Sum of Squares | 5681157.5T |
Sarepta Cash History
Other Fundumenentals of Sarepta Therapeutics
| Cash And Short Term Investments | ||
| Change In Cash | ||
| Free Cash Flow | ||
| Other Cashflows From Financing Activities |
Sarepta Therapeutics Cash component correlations
Click cells to compare fundamentals
About Sarepta Therapeutics Financial Statements
Sarepta Therapeutics shareholders use historical fundamental indicators, such as Cash, to determine how well the company is positioned to perform in the future. Although Sarepta Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Sarepta Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Sarepta Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sarepta Stock Analysis
When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.